Aktis Oncology, Inc. Common stock (AKTS) — Long-term Investment Intensity
Aktis Oncology, Inc. Common stock (AKTS) has a Long-term Investment Intensity of 0.0% as of June 2020. Long-term investments of $21.00K represent 0.0% of total assets of $71.43 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Aktis Oncology, Inc. Common stock (AKTS) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Aktis Oncology, Inc. Common stock Long-term Investment Intensity (2018–2020)
This chart shows how Aktis Oncology, Inc. Common stock's Long-term Investment Intensity has evolved across 3 annual periods from 2018 to 2020. As of June 2020, the intensity stands at 0.0%, reflecting long-term investments of $21.00K against total assets of $71.43 Million USD. Explore Aktis Oncology, Inc. Common stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Aktis Oncology, Inc. Common stock (2018–2020)
The table below presents the year-by-year Long-term Investment Intensity for Aktis Oncology, Inc. Common stock from 2018 to 2020, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see AKTS stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 0.0% | $21.00K | $71.43 Million | ▼ -0.6 pp |
| 2019 | 0.6% | $300.00K | $47.95 Million | ▼ -0.5 pp |
| 2018 | 1.1% | $333.25K | $29.31 Million | — |